Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Primary Myelofibrosis 13Myeloproliferative Disorders 9Leukemia, Myeloid, Acute 8Thrombocythemia, Essential 6Polycythemia Vera 6Myelodysplastic Syndromes 5Leukemia 5Lymphoma, T-Cell 4Recurrence 3Neoplasms 3Graft vs Host Disease 3Myelodysplastic-Myeloproliferative Diseases 2Lymphoma, T-Cell, Cutaneous 2Lymphoma 2Leukemia, Prolymphocytic, T-Cell 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Hematologic Neoplasms 2Uveal Melanoma 1Thalassemia 1Targeted Therapy 1Prostatic Neoplasms 1Preleukemia 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Neoplasms by Histologic Type 1Mycosis Fungoides 1Multiple Myeloma 1Mesothelioma 1Melanoma 1Lymphoma, T-Cell, Peripheral 1

Interventions

ibrutinib 2fludarabine 2asciminib 2Sirolimus 2Mycophenolic Acid 2Cyclophosphamide 2ruxolitinib 1axatilimab 1Whole-Body Irradiation 1Specimen Handling 1Panobinostat 1Mesna 1Filgrastim 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bronchiolitis Obliterans Syndrome × ruxolitinib × 90 days × Clear all
NCT02386800 2026-05-27

CINC424A2X01B Rollover Protocol

Novartis

Phase 4 Active not recruiting
279 enrolled
MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Polycythemia Vera, Thalassemia, Leukemia, Myeloid, Acute, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡